You are here: Industry Insights > Antengene

News List

Antengene, WuXi Biologics Ink Innovative Oncology R&D Alliance contractpharma
October 14, 2020
Partner for the development and production of novel drugs, and to jointly promote R&D of innovative oncology therapies.
Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization prnasia
July 20, 2020
Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully clos
Celgene invests in Chinese biotech Antengene again fiercebiotech
January 04, 2019
China’s Antengene has raised another $120 million in a second-round financing, with partner Celgene contributing to the tally....
China’s Antengene raises $120m to boost drug development pharmaceutical-technology
January 03, 2019
Chinese biopharmaceutical firm Antengene has raised $120m in a series B funding round led by Boyu Capital and FountainVest to support the development and commercialisation of new therapeutics.
China’s Antengene raises $120m to boost drug development pharmaceutical-technology
January 03, 2019
Chinese biopharmaceutical firm Antengene has raised $120m in a series B funding round led by Boyu Capital and FountainVest to support the development and commercialisation of new therapeutics.....

Previous page 1 2 3 4 5 Next page